NBCC Share Price in Focus; Proposes Merger Of Wholly Owned Subsidiary HSCC

NBCC (India) Ltd. has proposed the merger of its wholly owned subsidiary HSCC (India) Ltd. with the parent company under a Scheme of Arrangement approved by its board.
NBCC to Merge HSCC with Parent Company
The company informed the stock exchanges that HSCC will be amalgamated with NBCC under the proposed scheme.
The appointed date for the merger has been fixed as April 1, 2026, although the scheme will become effective only after receiving all necessary approvals from the competent authorities.
No Equity Shares to Be Issued
As HSCC is a wholly owned subsidiary of NBCC, the merger will not involve the issuance of any new equity shares.
The company's existing investment in HSCC will stand cancelled upon the scheme becoming effective, and no consideration will be payable under the transaction.
Merger Aims to Improve Operational Efficiency
According to NBCC, the merger is expected to eliminate duplication of functions, simplify the corporate structure and improve resource utilisation across the combined entity.
The company also expects the integration to reduce administrative, legal and regulatory compliance costs while enabling faster decision-making and improving overall operational efficiency.
Read More: Cipla Share Price in Focus; USFDA Inspects InvaGen Facility, Receives One Form 483 Observation!
NBCC Share Price Performance
As of 17 July 2026, NBCC share price was trading at ₹97.25 per share, reflecting a decline of 0.05% from the previous trading session.
Conclusion
The proposed merger is expected to create a more streamlined organisation by integrating HSCC's operations with NBCC, allowing the company to improve execution capabilities, optimise costs and strengthen its position in the infrastructure and healthcare project management segments.
Want to read stock market updates in Hindi? Angel One News gives comprehensive share market news in Hindi.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Jul 18, 2026, 5:53 PM IST

Team Angel One
- RPG Life Sciences Share Price Crashes Over 10% After Q2 FY27 Results
- ACME Solar Share in Focus as Subsidiary Collaborates with NTPC on 400 MW Renewable Energy Project
- Hikal Share Price Gains Over 8%; Achieves Swissmedic GMP Certification for Bengaluru Facility
- Sun Pharma Share Price Gains Nearly 2%; Secures FDA Approval for ILUMYA in Treating Psoriatic Arthritis
- Best Long-Term Stocks in November 2026 Based on 5 Year CAGR: BSE, Adani Power and More




